A new, cost-effective barrier enclosure protects healthcare workers by effectively containing airborne viral particles from COVID-19 patients.
The amount of neutralizing antibodies produced by COVID-19 patients—and the length of time they remain detectable—can vary wildly, a study suggests.
Understanding why COVID-19 tends to strike the old but spare the young could inform how to prioritize limited COVID-19 vaccines.
In a classic case of double trouble, the binding of SARS-CoV-2’s spike protein to bacterial lipopolysaccharide supercharges inflammation in COVID-19 patients.
Lockdown measures not only reduced the number of COVID-19 cases but also resulted in a temporary improvement in air quality, study finds.
Using flow cytometry, researchers have developed a sensitive and specific test for COVID-19 that can identify asymptomatic carriers.
Plant-based ionizers are surprisingly effective at removing aerosols and could play an important role in preventing COVID-19 transmission.
A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.
By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.
A*STAR researchers use digital drug simulators to predict the efficacies of repurposed antivirals for treating COVID-19.
This ‘smart mask’ designed by A*STAR researchers may reduce the risk of infection in healthcare workers by enabling remote, real-time monitoring of patients’ symptoms.